Meitheal Pharmaceuticals, Inc recalls Vecuronium Bromide for Injection
- Recalling company
- Meitheal Pharmaceuticals, Inc
- Product
- Vecuronium Bromide for Injection, 10mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL. NDC: 71288-744-11
- Reason
- Labeling: Label Lacks Warning or Rx Legend
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- Oct 8, 2026
- Reported
- Nov 4, 2026
- Distribution
- US. Nationwide
- Status
- Ongoing
- Quantity
- 121,800 vials
- Lot / codes
- Lot# T1P0213A: Exp. 30-Apr-29 Lot# T1P0313A: Exp. 30-Apr-29 Lot# T1P0412A: Exp. 30-Sep-28 Lot# T1P0413A: Exp. 30-Apr-29 Lot# T1P0512A: Exp. 30-Sep-28 Lot# T1P0513A: Exp. 30-Apr-29
- Company location
- Chicago, IL
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0108-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0108-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.